"L'Ente Ospedaliero Specializzato in Gastroenterologia "Saverio de Bellis" è una struttura ospedaliera ad indirizzo specialistico gastroenterologico medico e chirurgico che opera in tale campo quale Istituto di Ricovero e Cura a Carattere Scientifico di diritto pubblico."

During the past decade, IRCCS Saverio de Bellis conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 5 clinical trials were completed, i.e. on average, 17.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 3 clinical trials were completed. i.e. 18.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IRCCS Saverio de Bellis" #1 sponsor was "Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis" with 21 trials, followed by "Celgene" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Saverio de Bellis" #1 collaborator was "Antonella, Orlando" with 1 trials as a collaborator, "Antonia, Ignazzi" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "BAYER S.p.A. - Italia" with 1 trials as a collaborator and "Benedetta, D Attoma" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS Saverio de Bellis" are "Obesity" (8 trials), "Ulcerative Colitis" (4 trials), "Crohn Disease" (3 trials), "NAFLD" (3 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "IRCCS Saverio de Bellis" in a lesser frequency.

Most popular intervention types in "IRCCS Saverio de Bellis" are "Drug" (14 trials), "Other" (12 trials), "Dietary Supplement" (7 trials), "Behavioral" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Observational" (4 trials), "Etrasimod" (3 trials), "Low Glycemic Index Mediterranean Diet" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Saverio de Bellis" are 35 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS Saverio de Bellis". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 22 completed trials in IRCCS Saverio de Bellis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Saverio de Bellis, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".

IRCCS Saverio de Bellis has several departments that took part in Clinical trials: "UOC Gastroenterologia II" - 4 trials